SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-056724
Filing Date
2020-12-10
Accepted
2020-12-10 16:13:58
Documents
66
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avir-10q_20200930.htm 10-Q 2077278
2 EX-31.1 avir-ex311_11.htm EX-31.1 18038
3 EX-31.2 avir-ex312_10.htm EX-31.2 17977
4 EX-32.1 avir-ex321_9.htm EX-32.1 9403
5 EX-32.2 avir-ex322_8.htm EX-32.2 9419
  Complete submission text file 0001564590-20-056724.txt   6053498

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT avir-20200930.xml EX-101.INS 1020706
7 XBRL TAXONOMY EXTENSION SCHEMA avir-20200930.xsd EX-101.SCH 45709
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avir-20200930_cal.xml EX-101.CAL 25859
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avir-20200930_def.xml EX-101.DEF 162458
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE avir-20200930_lab.xml EX-101.LAB 344588
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avir-20200930_pre.xml EX-101.PRE 296839
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39661 | Film No.: 201380710
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences